49 minutes ago
- copy link
US Senator Jim Banks has asked the FDA (Food and Drug Administration) to more strictly investigate the medicines coming from India and China.
They say that the quality of some medicines may be poor and it may pose a threat to American consumers.
The senators wrote a letter to FDA Commissioner Martin Macari asking him to increase oversight of foreign drug manufacturing factories and make the US drug supply safer. He warned that if testing remained lax, the American people could be exposed to bad drugs.
According to FDA data, of the factories that received import warnings, about 39% were in China and 13% were in India. In fiscal year 2024, the FDA inspected only 28% of Chinese and 33% of Indian factories. Serious violations were also found among some manufacturers in India.
Also read this news related to international affairs…
Lawsuit filed against Trump for increasing H1-B visa fees; American Chamber of Commerce filed a case
The US Chamber of Commerce has filed a lawsuit against the Trump administration over increasing the fees for H-1B visas.
Last month, the Trump administration decided to increase the application fee for H-1B visa from $1 thousand to $1 lakh.
The Chamber says this fee is illegal and will cause serious harm to American companies.
The court has been told that President Donald Trump has imposed this fee beyond his authority and federal agencies should be prevented from implementing it.
H-1B visa is for high-skilled workers. Most H-1B visas are given to Indian workers. Big tech companies use this visa the most. However, essential workers like teachers and doctors are also covered under this visa.
———————————
Read the world updates of October 16 here….
Source link
[ad_3]
